Affinage

PKP3

Plakophilin-3 · UniProt Q9Y446

Length
797 aa
Mass
87.1 kDa
Annotated
2026-06-10
16 papers in source corpus 7 papers cited in narrative 7 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 3/3 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PKP3 is a plakophilin-subfamily catenin that functions as a signaling adaptor coupling membrane and cytoplasmic signaling to transcriptional and cell-fate outcomes. It participates in canonical Wnt signaling: PKP3 protein is stabilized by Wnt-ligand or dominant-active LRP6 stimulation and destabilized by the destruction-complex components GSK3β and Axin, with which it physically associates; upon Wnt stimulation it translocates to the nucleus and activates a Wnt transcriptional reporter (PMID:34058472). PKP3 also influences cell proliferation and survival through its post-transcriptional regulation, as it is a direct target of miR-10b-5p and acts to sustain RIPK3/MLKL necroptosis signaling, such that loss of PKP3 promotes proliferation and reduces necroptosis in lung adenocarcinoma (PMID:40116080). PKP3 expression is further controlled epigenetically through a methylation-dependent regulatory sequence in its gene body that drives promoter activity in lung epithelial cells (PMID:34415821). Beyond these axes, direct biochemical mechanisms linking PKP3 to downstream effectors remain incompletely characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2018 Low

    Established that PKP3 levels are subject to microRNA control, framing it as a regulated node rather than a static structural protein, with functional consequences for tumor cell behavior.

    Evidence miR-149 overexpression/inhibitor rescue and Western blot for PKP3 in nasopharyngeal carcinoma cells

    PMID:30144176

    Open questions at the time
    • No direct 3'UTR luciferase validation of miR-149 targeting reported
    • Single lab, single cancer model
    • Mechanism linking PKP3 loss to migration/invasion not biochemically defined
  2. 2018 Low

    Addressed how PKP3 influences cell proliferation and invasion, placing it upstream of MAPK-JNK-ERK1/2-mTOR signaling and autophagy.

    Evidence siRNA knockdown and overexpression in ovarian cancer cells with Western blot of pathway components and invasion/proliferation assays

    PMID:30527804

    Open questions at the time
    • Pathway placement inferred from KD/OE, not direct PKP3-MAPK biochemical interaction
    • No reconstitution of the proposed signaling chain
    • Single lab
  3. 2021 Medium

    Defined a direct link between PKP3 and canonical Wnt signaling, showing PKP3 is a destruction-complex-regulated factor that enters the nucleus to drive Wnt-responsive transcription.

    Evidence Co-IP with GSK3β and Axin, Wnt-ligand/dominant-active LRP6 stability assays, nuclear localization imaging, and Wnt luciferase reporter

    PMID:34058472

    Open questions at the time
    • Direct nuclear transcriptional targets of PKP3 not identified
    • Single lab
    • Stoichiometry and structural basis of GSK3β/Axin association unknown
  4. 2021 Medium

    Showed that PKP3 expression is itself epigenetically controlled, identifying a methylation-dependent regulatory sequence in its gene body active in lung epithelial cells.

    Evidence Luciferase reporter assays comparing methylated and unmethylated PKP3 gene-body sequence

    PMID:34415821

    Open questions at the time
    • Endogenous methylation status across tissues not mapped
    • Transcription factors acting at this element not identified
  5. 2023 Low

    Extended the PKP3/MAPK axis to a downstream effector, linking PKP3 to ERCC1 expression and to promoter-methylation-based regulation in ovarian granulosa cells.

    Evidence OE/KD of PKP3 and ERCC1 with Western blot for MAPK, promoter methylation analysis, proliferation/apoptosis assays

    PMID:37420272

    Open questions at the time
    • No direct biochemical reconstitution of the PKP3/MAPK/ERCC1 axis
    • Promoter methylation assessed indirectly
    • Single lab
  6. 2024 Low

    Positioned PKP3 within an upstream regulatory cascade, showing FERMT1 acts through PKP3 to activate p38 MAPK and drive lung cancer migration/invasion.

    Evidence FERMT1 overexpression with PKP3 knockdown epistasis, Western blot for p38 MAPK, Transwell assays in NSCLC

    PMID:38200443

    Open questions at the time
    • No direct FERMT1-PKP3 or PKP3-p38 physical interaction shown
    • Epistasis inferred from KD/OE only
    • Single lab
  7. 2025 Medium

    Resolved a direct post-transcriptional regulator and a cell-death output, validating PKP3 as a miR-10b-5p target that sustains RIPK3/MLKL necroptosis signaling.

    Evidence Dual luciferase 3'UTR reporter, RIPK3/MLKL Western blot, knockdown rescue, and xenograft model in lung adenocarcinoma

    PMID:40116080

    Open questions at the time
    • Mechanism by which PKP3 sustains RIPK3/MLKL activity not defined
    • Direct physical interaction with necroptosis machinery not shown
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PKP3's desmosomal/structural role integrates with its signaling functions in Wnt, MAPK, and necroptosis, and what its direct transcriptional or effector partners are, remains unresolved.
  • No direct PKP3 transcriptional targets identified
  • No structural model of signaling complexes
  • Integration of multiple pathway roles not reconciled in one system

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060089 molecular transducer activity 1 GO:0140110 transcription regulator activity 1
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-162582 Signal Transduction 1 R-HSA-5357801 Programmed Cell Death 1
Partners

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2021 PKP3 protein levels are stabilized in response to canonical Wnt pathway activation (Wnt ligand or dominant-active LRP6 receptor), and conversely reduced by destruction-complex components GSK3β and Axin. PKP3 physically associates with GSK3β and Axin. Upon Wnt ligand stimulation, PKP3 trans-localizes into the nucleus and stimulates a Wnt transcriptional reporter. Co-immunoprecipitation (association with GSK3β and Axin), dominant-active LRP6 and Wnt-ligand stimulation assays for protein level changes, nuclear localization imaging, luciferase Wnt reporter assay Biochemical and biophysical research communications Medium 34058472
2018 PKP3 activates the MAPK-JNK-ERK1/2-mTOR pathway to regulate autophagy and invasion in ovarian cancer cells; silencing PKP3 decreases proliferation and invasion, while PKP3 overexpression increases them through mTOR-mediated autophagy regulation. siRNA-mediated PKP3 knockdown and PKP3 overexpression in SKOV3/A2780 cells; Western blotting for MAPK/mTOR pathway components; invasion and proliferation assays Biochemical and biophysical research communications Low 30527804
2024 FERMT1 upregulates PKP3 expression, which in turn activates the p38 MAPK signaling pathway to promote migration and invasion in non-small cell lung cancer; PKP3 knockdown counteracts the p38 MAPK activation induced by FERMT1 overexpression. Western blotting for p38 MAPK pathway components; Transwell migration/invasion assays; siRNA knockdown of PKP3; FERMT1 overexpression BMC cancer Low 38200443
2025 PKP3 is a direct target of miR-10b-5p (confirmed by dual luciferase reporter assay); miR-10b-5p downregulates PKP3, which in turn suppresses the RIPK3/MLKL necroptosis signaling pathway, thereby increasing cell proliferation and decreasing necroptosis in lung adenocarcinoma. Dual luciferase reporter assay for miR-10b-5p targeting of PKP3 3'UTR; Western blot for RIPK3/MLKL pathway; PKP3 knockdown rescue experiments; in vivo xenograft mouse model Oncology reports Medium 40116080
2023 PKP3 augments ERCC1 expression by activating the MAPK pathway in ovarian granulosa cells; CFDTW treatment reduces PKP3 expression by enhancing methylation of the PKP3 promoter, thereby modulating granulosa cell proliferation and apoptosis through the PKP3/MAPK/ERCC1 axis. PKP3/ERCC1 overexpression and knockdown in ovarian granulosa cells; Western blotting for MAPK components; methylation analysis of PKP3 promoter; cell proliferation and apoptosis assays Journal of ovarian research Low 37420272
2021 A sequence in the gene body of PKP3 exhibits methylation-dependent promoter activity in lung epithelial cells, as demonstrated by luciferase reporter assays in the presence and absence of methylation. Luciferase reporter assay with methylated and unmethylated PKP3 gene-body sequence in lung epithelial cells Epigenetics Medium 34415821
2018 DNP (N,N'-dinitrosopiperazine) decreases PKP3 expression in nasopharyngeal carcinoma cells through upregulation of miR-149, which targets PKP3; this decrease in PKP3 contributes to increased NPC cell proliferation, adhesion, migration, and invasion. miR-149 inhibitor rescue experiments; miR-149 overexpression; Western blotting for PKP3; cell migration/invasion assays Molecular carcinogenesis Low 30144176

Source papers

Stage 0 corpus · 16 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Human pathology 62 12827610
2012 Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. The Journal of infectious diseases 48 22223854
2011 Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. Diagnostic pathology 41 21194493
2011 Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Medical oncology (Northwood, London, England) 34 21947748
2018 PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer. Biochemical and biophysical research communications 32 30527804
2017 First report of blaOXA-181-mediated carbapenem resistance in Aeromonas caviae in association with pKP3-A: Threat for rapid dissemination. Journal of global antimicrobial resistance 25 28743649
2018 Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis. Molecular carcinogenesis 16 30144176
2016 Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants. PloS one 15 26872154
2021 A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals. Biochemical and biophysical research communications 13 34058472
2023 Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis. Journal of ovarian research 12 37420272
2024 FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling. BMC cancer 10 38200443
2021 Analysis of Multiple Human Tumor Cases Reveals the Carcinogenic Effects of PKP3. Journal of healthcare engineering 6 34733461
2025 KRT6A, KRT6B, PKP1, and PKP3 as key hub genes in esophageal cancer: A combined bioinformatics and experimental study. Biochemistry and biophysics reports 4 40612005
2021 Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells. Epigenetics 3 34415821
2025 Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade. Oncology reports 2 40116080
2025 CircFOXK2 induces non-small cell lung cancer tumorigenesis through the miR-328-5p/PKP3 axis. Cellular and molecular biology (Noisy-le-Grand, France) 0 41351372

Missed literature

Know a paper Affinage missed for PKP3? Flag it for the maintainers and the community.

No submissions yet.